SimvastatinDrug Therapy, CombinationHydroxymethylglutaryl-CoA Reductase InhibitorsAnticholesteremic AgentsArtemisininsDrug CombinationsAzetidinesTreatment OutcomeHypolipidemic AgentsLovastatinAntimalarialsHeptanoic AcidsDrug SynergismRibavirinHypercholesterolemiaFluorenesPyrrolesAntiviral AgentsInterferon-alphaAntineoplastic Combined Chemotherapy ProtocolsEthanolaminesDose-Response Relationship, DrugDouble-Blind MethodPravastatinAmodiaquineCholesterol, LDLSesquiterpenesMevalonic AcidDrug InteractionsDrug Administration ScheduleCombined Modality TherapyMalaria, FalciparumNiacinCholesterolFluorobenzenesHepatitis C, ChronicTime FactorsCell Line, TumorMefloquineDisease Models, AnimalLipidsAntineoplastic AgentsPolyethylene GlycolsAntihypertensive AgentsAdministration, OralFenofibrateSulfadoxinePyrimethaminePolyisoprenyl PhosphatesMalariaDrug ResistanceXenograft Model Antitumor AssaysSulfasalazineChloroquineHydrochlorothiazidePlasmodium falciparumLamivudineOrganophosphonatesApoptosisSulfonamidesCross-Over StudiesAnti-Inflammatory AgentsRhabdomyolysisPyrimidinesDeoxycytidineAmlodipineMice, NudeDrug Evaluation, PreclinicalPyrazinesAntibodies, MonoclonalAngiotensin-Converting Enzyme InhibitorsClinical Trials as TopicAnti-Bacterial AgentsRecombinant ProteinsTetrazolesAntirheumatic AgentsCell ProliferationMethotrexate